14064 Multiple System Atrophy: Prognostic Indicators of Survival August 29, 2014
Weekly grand rounds as a forum for clinical and basic research updates in neurology with respect to diagnosis and management of neurological disorders and advances in neuroscience. General areas of focus will include among others the following: neuromuscular, epilepsy, sleep, movement disorders, stroke and vascular disorders, neurodegenertive, dementia and memory disorders, headaches and cranial neuralgias, autonomic disorders, and general neurologic conditions.
Neurologists and Neuropsychologists as a specialty, including both generalists and sub-specialists. Health care providers including physicians (MD's, DO's) RN, APNP, PA, PhD, as well as students, residents, and fellows. Also included are basic and clinical researchers and clinicians throughout neurology, neurosurgery, and neuropsychology especially during the monthly interdisciplinary grand rounds presentations.
- Describe the early neurological and autonomic manifestation of multiple system atrophy (MSA)
- Identify the wide variability of prognosis in MSA
- Understand the impact of early autonomic involvement in survival in MSA
David Sabsevitz, PhD, ABPP
All persons in control of content have NO relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.